Related Experiment Video
Updated: May 1, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Total synthesis of ryanodol.
Masanori Nagatomo1, Masaki Koshimizu, Kengo Masuda
1Graduate School of Pharmaceutical Sciences, The University of Tokyo , Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Researchers synthesized ryanodol, a complex natural product and calcium release channel modulator. This novel synthetic strategy enables the creation of new ryanodine derivatives with altered functional properties.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Chemical Biology
Background:
- Ryanodol (1) is a natural product derivative, ryanodine, that modulates calcium release channels.
- Ryanodol possesses a complex pentacyclic structure with eight oxygen and three methyl groups, and numerous stereocenters.
Purpose of the Study:
- To achieve the total synthesis of the complex natural product ryanodol.
- To develop a novel and flexible synthetic strategy for generating ryanodine derivatives.
Main Methods:
- Total synthesis of ryanodol (1) in 22 steps from a C2-symmetric tricycle (8).
- Installation of seven stereogenic centers and formation of four C-C bonds within a congested multicyclic framework.
Main Results:
- Successfully synthesized the exceptionally complex ryanodol molecule.
- Developed a flexible strategy applicable to generating diverse chemical derivatives.
Conclusions:
- The total synthesis of ryanodol was accomplished.
- The developed synthetic route provides a platform for creating novel ryanodine analogs for calcium release channel research.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Inotropic Agents
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

